Skip to content

Divided Drug Delivery

Divided Drug Delivery : a Way to Prevent Repeated Volutary Drug Intoxications.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02869724
Acronym
DEFIMED-1
Enrollment
30
Registered
2016-08-17
Start date
2014-03-31
Completion date
2017-03-31
Last updated
2016-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hospitalized for Voluntary Drug Intoxication

Keywords

IMV : voluntary drug intoxications, Drug, Divided prescription

Brief summary

This study will evaluate the efficacy of an advice with a weekly divided drug delivery, compared to an usual monthly delivery in the prevention of voluntary drug intoxications repeated.

Interventions

OTHERWeekly divided delivery
OTHERMonthly divided delivery

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women between 18 and 65 years. * Hospitalized after a voluntary drug intoxication. * History of two voluntary drug intoxications at least. * Person registered for social security. * Signed free consent.

Exclusion criteria

* Patients under treatment for opiate split * Acute or chronicgoing wild. * Cognitive problems hindering understanding of questionnaires * Persons targeted by articles L1121-5 to L1121-8 of CSP

Design outcomes

Primary

MeasureTime frameDescription
Evaluate the efficacy of an advice with a weekly divided drug delivery, compared to an usual monthly delivery in the prevention of voluntary drug intoxications repeated6 monthsNumber of cumulative voluntary drug intoxications throughout the 6 months

Countries

France

Contacts

Primary ContactMaurice Dematteis, Professor
MDematteis@chu-grenoble.fr+66236
Backup ContactMichel Mallaret, Doctor
mmallaret@chu-grenoble.fr04 76 76 41 55

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026